Asia Pacific Orthopedic Regenerative Surgical Products Market Size & Outlook
Related Markets
Asia Pacific orthopedic regenerative surgical products market highlights
- The Asia Pacific orthopedic regenerative surgical products market generated a revenue of USD 855.6 million in 2022.
- The market is expected to grow at a CAGR of 5.3% from 2023 to 2030.
- In terms of segment, viscosupplements was the largest revenue generating product in 2022.
- Allografts is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 855.6 million |
| Market revenue in 2030 | USD 1,294.6 million |
| Growth rate | 5.3% (CAGR from 2022 to 2030) |
| Largest segment | Viscosupplements |
| Fastest growing segment | Allografts |
| Historical data covered | 2016 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
| Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.6% of the global orthopedic regenerative surgical products market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,294.6 million by 2030.
Key Regions: Brazil , Japan , U.S. , UK , South Africa
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Orthopedic Regenerative Surgical Products Market Scope
Orthopedic Regenerative Surgical Products Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Aptissen | View profile | 11-50 | Plan-les-ouates, Geneve, Switzerland, Europe | http://www.aptissen.com |
| VSY Biotechnology | View profile | 251-500 | Leinfelden-echterdingen, Baden-Wurttemberg, Germany, Europe | https://www.vsybiotechnology.com |
| AlloSource | View profile | 501-1000 | Centennial, Colorado, United States, North America | https://www.allosource.org/ |
| Arthrex | View profile | 5001-10000 | Naples, Florida, United States, North America | https://www.arthrex.com/ |
| BioTissue | View profile | 1-10 | Genève, Geneve, Switzerland, Europe | http://www.biotissue.ch |
| MiMedx Group Inc | View profile | 895 | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 | https://www.mimedx.com |
| Vericel Corp | View profile | 314 | 64 Sidney Street, Cambridge, MA, United States, 02139 | https://www.vcel.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Asia Pacific orthopedic regenerative surgical products market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 47.11% in 2022. Horizon Databook has segmented the Asia Pacific orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
This is owing to the developing healthcare infrastructure, regional expansion by key players, and rising prevalence of orthopedic disorders, such as osteoarthritis.
According to the Australian Institute of Health and Welfare, Government of Australia, one in seven adults have some form of arthritic condition, out of which one in two Australians experienced moderate to severe pain.Growing spending on healthcare, improving medical tourism, and rapidly evolving healthcare infrastructure in the region are among the factors anticipated to promote market growth.
For instance, South Korea has a developed healthcare system and provides medical services at low cost. The South Korean government is undertaking initiatives to boost medical tourism in the country, as it is one of the most common medical tourism destinations across the globe.
Reasons to subscribe to Asia Pacific orthopedic regenerative surgical products market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific orthopedic regenerative surgical products market databook
-
Our clientele includes a mix of orthopedic regenerative surgical products market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific orthopedic regenerative surgical products market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific orthopedic regenerative surgical products market size, by country, 2016-2030 (US$M)
Asia Pacific Orthopedic Regenerative Surgical Products Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
